Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Hypoxemia

New insights into treatment with oxygen in intensive care medicine

    • Anesthesiology
    • Pneumology
    • RX
    • Studies
  • 2 minute read

The New England Journal of Medicine (NEJM) recently published the large-scale multinational study “Handling Oxygenation Targets in the Intensive Care Unit” (HOT-ICU). Under the direction of Aalborg University Hospital, the survival rate of critically ill patients with acute pulmonary function limitation (hypoxemia) was studied. One group with lower and one with higher target oxygen levels were compared. Contrary to the original assumption, the mortality rate after 90 days was comparable in both groups.

Critically ill patients with lung dysfunction are often treated with oxygen in intensive care units. Oxygen, one of the oldest and most widely used drugs, is often supplied by mechanical ventilation, and a certain oxygen partial pressure (oxygen target value) in the blood is aimed for. However, different strategies with either higher or lower oxygen partial pressure are used in intensive care units worldwide. In intensive care practice and in the scientific literature, the respective benefits or risks of corresponding strategies remained unclear.

Surprising results

The results of the HOT-ICU study show no difference in 90-day mortality when critically ill patients in the higher (n = 1447.90 mmHg arterial partial pressure) and lower (n = 1441.60 mmHg arterial partial pressure) target group are compared. Thus, a lower target oxygen value does not reduce mortality after 90 days. Similarly, no significant difference was found for the criteria “proportion of days without life-sustaining measures” and “proportion of days without hospitalization”. 

Large-scale multinational study

The HOT-ICU pragmatic study was conducted by a scientific team led by Aalborg University Hospital at 35 intensive care centers in Denmark, Finland, the Netherlands, Norway, the United Kingdom, Iceland, and Switzerland (Basel and Bern University Hospitals). It included 2928 adult critically ill patients with an oxygen demand of at least 10 liters per minute or an inspired oxygen percentage of 50%. Allocation to the two treatment groups (90 mmHg or 60 mmHg arterial partial pressure of oxygen) was randomized. The primary endpoint of the study was mortality at 90 days. The number of days without (necessary) life-sustaining measures, the number of days without hospitalization, and the ratio of patients with shock, myocardial infarction, stroke, and gastrointestinal circulatory disorders were also documented. 

Outlook

After intensive discussions on the strategy of target oxygen levels in critically ill patients in recent years and arguments for and against both approaches, the current study results seem to support a “conservative” oxygen administration with lower target oxygen levels in adult critically ill patients. Prof. Joerg C. Schefold, MD, Chief of the Department of Intensive Care Medicine at Inselspital, University Hospital Bern, and member of the scientific team explains: “The study results on this everyday intensive care question are important because they contribute to a better understanding of the effects of corresponding strategies. They show that the ‘conservative’ strategy is not associated with a lower mortality rate. We expect our data to influence international recommendations regarding target oxygen levels to aim for in adult critically ill patients requiring oxygen supplementation.”

Source: University Hospital Bern

Original publication:

DOI: 10.1056/NEJMoa2032510, Publication in NEJM “Lower or Higher Oxygenation Targets for Acute Hypoxemic Respiratory Failure.”

Previous Article
  • REMAP-CAP Study Group

COVID-19: New treatment recommendations in intensive care units.

  • Anesthesiology
  • Infectiology
  • News
  • RX
  • Studies
View Post
Next Article
  • Venous thromboembolism

Risks associated with hormone therapy

  • Cardiology
  • CME continuing education
  • Education
  • Endocrinology and Diabetology
  • General Internal Medicine
  • Gynecology
  • Neurology
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 6 min
  • Hair loss

Controversy over the benefits of biotin supplementation: what is evidence-based?

    • Dermatology and venereology
    • Education
    • General Internal Medicine
    • Nutrition
    • RX
    • Studies
View Post
  • 5 min
  • New findings on known forms of therapy

Fatigue syndrome as a leading symptom in multiple sclerosis

    • Education
    • Neurology
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 5 min
  • Asthma in adults

When do pneumology specialists come into play?

    • RX
View Post
  • 10 min
  • Cutaneous lupus erythematosus

From diagnostic workup to successful treatment

    • Congress Reports
    • Dermatology and venereology
    • RX
    • Studies
View Post
  • 4 min
  • Guideline update

Dietary recommendations for Crohn’s disease and colitis

    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Nutrition
    • RX
    • Studies
View Post
  • 4 min
  • Circadian rhythm during Ramadan

Disturbed sleep patterns lead to metabolic stress

    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nutrition
    • RX
    • Studies
View Post
  • 6 min
  • Case Report

Breast cancer metastases in the bladder

    • Cases
    • Education
    • Gynecology
    • Oncology
    • RX
    • Urology
View Post
  • 11 min
  • Findings from the ALS Symposium 2024 in Montreal

Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)

    • Congress Reports
    • Interviews
    • Neurology
    • RX
    • Studies
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Patience, knowledge and persistence in therapy
  • 2
    Sarcopenia and malnutrition in the context of pneumological rehabilitation
  • 3
    Medical and psychosocial perspectives
  • 4
    New nomenclature for non-alcoholic fatty liver disease
  • 5
    Examinations and considerations before therapy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.